Lord, Abbett & Co’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $12.7M | Sell |
|
|||||
|
2024
Q4 | $19.9M | Sell |
|
|||||
|
2024
Q3 | $21.4M | Buy |
|
|||||
|
2024
Q2 | $21.2M | Buy |
|
|||||
|
2024
Q1 | $27.6M | Sell |
|
|||||
|
2023
Q4 | $24.1M | Sell |
|
|||||
|
2023
Q3 | $20.2M | Buy |
|
|||||
|
2023
Q2 | $21.6M | Sell |
|
|||||
|
2023
Q1 | $26.1M | Sell |
|
|||||
|
2022
Q4 | $28.4M | Buy |
|
|||||
|
2022
Q3 | $22.9M | Buy |
|
|||||
|
2022
Q2 | $24.7M | Buy |
|
|||||
|
2022
Q1 | $30.3M | Sell |
|
|||||
|
2021
Q4 | $42M | Sell |
|
|||||
|
2021
Q3 | $49.9M | Sell |
|
|||||
|
2021
Q2 | $54.8M | Sell |
|
|||||
|
2021
Q1 | $52.7M | Sell |
|
|||||
|
2020
Q4 | $49.8M | Sell |
|
|||||
|
2020
Q3 | $51.4M | Sell |
|
|||||
|
2020
Q2 | $48.2M | Sell |
|
|||||
|
2020
Q1 | $38M | Sell |
|
|||||
|
2019
Q4 | $55.9M | Sell |
|
|||||
|
2019
Q3 | $58.6M | Sell |
|
|||||
|
2019
Q2 | $69.7M | Sell |
|
|||||
|
2019
Q1 | $98.6M | Sell |
|
|||||
|
2018
Q4 | $96M | Sell |
|
|||||
|
2018
Q3 | $124M | Buy |
|
|||||
|
2018
Q2 | $85.1M | Buy |
|
|||||
|
2018
Q1 | $50.5M | Sell |
|
|||||
|
2017
Q4 | $73.7M | Sell |
|
|||||
|
2017
Q3 | $81.5M | Buy |
|
|||||
|
2017
Q2 | $65.9M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $28.8M | Sell |
|
|||||
|
2016
Q2 | $29.9M | Buy |
|
|||||
|
2016
Q1 | $26.4M | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $6.4M | Sell |
|
|||||
|
2015
Q1 | $63.3M | Buy |
|
|||||
|
2014
Q4 | $24.9M | Buy |
|
|||||
|
2014
Q3 | $13.4M | Buy |
|